HIMSS TV
Cue Health awarded $481M for coronavirus testing; public hospitals compounding COVID-19 budget risks
This week's top stories include Cue expecting to deliver six million COVID-19 molecular tests by March, while surging costs and revenue loss force hospitals to rely on support from county governments.
Dr. Art Papier, CEO of VisualDx, and Dr. Nada Elbuluk, the company's director of clinical impact, discuss the longstanding need to improve quality of care for people of color.
Telehealth Connection TV: Telehealth can be used to help with advance planning for end-of-life care, says the Cleveland Clinic's Dr. Silvia Perez-Protto.
Nuance VP of International Healthcare Operations Frederik Brabant says the company has developed tools that improve workflows, reducing the burden of clinical documentation and thus clinician burnout.
Deep Dive: Advocates, lawmakers and HIMSS Global Health Equity Network leaders talk about the disparities in maternal mortality and access to care among Black women, as well as the actions they're taking to address these social determinants of health.
Jayyou Choi, COO of QTT, discusses the importance of digital transformation and how technology can improve outcomes.
Virtually every stakeholder will need to play a role in transforming urban areas into smart communities, says NIST's Sokwoo Rhee.
Siemens Healthineers Senior Vice President Rahma Samow says AI-enabled decision making addresses critical data pain points along the patient's pathway.
HealthShare Exchange President and CEO Martin Lupinetti discusses lessons learned about data quality and reaching seniors during the COVID-19 crisis.
This week's top stories include HHS requiring hospitals to report flu data, Americans wanting mental healthcare via telehealth, and Clover Health joining the public market by merging with Social Capital SPAC.